Recognize at least three causes of maternal death
and identify patients at increased risk for mortality.ty.
• Discuss key elements for maternal-fetal assessment
including history, physical and clinical surveillance components.
• Review a variety of maternal conditions noting
anticipated fetal heart rate responses and nursing/medical
interventions.
• Describe use of NICHD nomenclature as a key
element in evaluating, communicating and responding to
maternal-fetal clinical presentation.
• Interpret obstetric values in common laboratory
evaluations, noting indications and clinical impact for care.
• Discuss essential elements for accuracy in B/P
measurements.
• Recognize the technical limitations of pulse
oximetry and describe how common errors may be avoided.
• Identity obstetric patients that may benefit from
invasive hemodynamic monitoring and discuss the concept of benefit
to risk ratio.
• Locate evidence-based resources for practice
guidelines for acquiring hemodynamic parameters including pressure
readings, PCOP values and COmeasurements.
• Describe the use of “Rescue” antihypertensive meds
in hypertensive crisis unresponsive to conventional therapy.
• Differentiate lab values consistent with HELLP
syndrome versus those indicative of DIC.
• Discuss ASA’s (American Society of
Anesthesiologists) new recommendations for managing hemorrhage and
its impact on OB care.
• Develop a plan to create and implement a Rapid
Response Team for postpartum hemorrhage to include the roles and
responsibilities needed.
• Discuss the benefits of “Team-Managed Directives”
used in emergencies and compare to traditional “provider-ordered”
treatments.
• Recall at least three cardiac lesions that are
classified as having the highest rates of maternal mortality.
• Describe plan of assessment and care for maternal
cardiac complications in Labor/Delivery.
